Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 9/20 | 0.46 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.39 |
| ▸ | TLR4 | O00206 | 1/20 | 0.39 |
| ▸ | TLR2 | O60603 | 1/20 | 0.39 |
| ▸ | ERN1 | O75460 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | ABL1 | P00519 | 1/20 | 0.37 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.37 |
| ▸ | CBFB | Q13951 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.36 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16595237 | 0.83 | FAAH (0.45) | FAAHPDK2TLR4TLR2ERN1 | |
| SCHEMBL13291983 | 0.78 | FAAH (0.44) | FAAHPDK2DRD2CYP2A6KCNH2 | |
| SCHEMBL28665803 | 0.78 | FAAH (0.44) | FAAHPDK2DRD2CYP2A6ABL1 | |
| SCHEMBL30664942 | 0.76 | FAAH (0.58) | FAAHABL1 | |
| SCHEMBL26656409 | 0.76 | FAAH (0.58) | FAAHABL1 | |
| SCHEMBL26656354 | 0.76 | FAAH (0.58) | FAAHABL1 | |
| SCHEMBL31404170 | 0.76 | FAAH (0.58) | FAAHABL1 | |
| SCHEMBL31404151 | 0.76 | FAAH (0.58) | FAAHABL1 | |
| SCHEMBL21557425 | 0.76 | FAAH (0.58) | FAAHABL1 | |
| SCHEMBL26818703 | 0.76 | FAAH (0.49) | FAAHABL1KCNH2MCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230132370-A9 | CRYSTAL FORMS OF THIAZOLE COMPOUND AND APPLICATION THEREOF | MEDSHINE DISCOVERY INC. (CN) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230132370-A9 | CRYSTAL FORMS OF THIAZOLE COMPOUND AND APPLICATION THEREOF | ZC3HAV1L, ZC3HAV1, RPL35 | FAAH 3654/4885PDK2 498/4885TLR4 281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.